Mechanism-based inactivation of cytochrome P450 2D6 by Notopterol

被引:8
作者
Fu, Yao [1 ]
Tian, Xiaoxiao [1 ]
Han, Lingling [1 ]
Li, Yilin [1 ]
Peng, Ying [1 ]
Zheng, Jiang [1 ,2 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Liaoning, Peoples R China
[2] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Key Lab Pharmaceut Guizhou Prov, Guiyang 550025, Guizhou, Peoples R China
[3] Guizhou Med Univ, Key Lab Environm Pollut Monitoring & Dis Control, Minist Educ, Guiyang 550025, Peoples R China
基金
中国国家自然科学基金;
关键词
Notopterol; Mechanism-based inactivation; CYP450; DRUG INTERACTION; IN-VITRO; CYP2D6; INHIBITION;
D O I
10.1016/j.cbi.2020.109053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Notopterol (NOT) is a major bioactive ingredient extracted from the rhizomes of either Notopterygium incisum Ting ex H. T. Chang or N. forbesii Boiss (Qianghuo in Chinese), a botanical drug that was adopted as a traditional Chinese medicine. NOT is suggested to show analgesic and anti-inflammatory effects in clinical practice. The inhibitory effects of NOT on human cytochrome P450 enzymes were investigated in the present study. Our results indicate that NOT inhibited the activity of CYP2D6 in a time-, concentration- and NADPH-dependent manner. The values of k(1) and k(in)(act) were 10.8 mu M and 0.62 min(-1), respectively. The calculated k(obs) at 10 mu M was 0.29 min(-1), above the 0.02 min(-1) risk level. After incubation with NOT at 10 mu M for 9 min, approximately 92% of CYP2D6 activity was inhibited. Such loss of enzyme activity was not restored through dialysis, which indicates that the observed enzyme inhibition was irreversible. Partition ratio of the inactivation was approximately 29. Quinidine, a competitive CYP2D6 inhibitor, demonstrated protection on enzymes against the NOT-induced inactivation, but such protection was not found in incubation systems fortified with glutathione or catalase/superoxide dismutase. Additionally, CYP3A4 was observed to function as an enzyme mainly involved in the biotransformation of NOT. Taken together, these findings indicate that NOT served as a mechanism-based inactivator of CYP2D6, meanwhile, those observed effects may induce the latent drug-drug interactions. The metabolic activation of NOT may be the key to trigger the inactivation of the enzyme.
引用
收藏
页数:9
相关论文
共 50 条
[31]   Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy [J].
Ververs, F. F. Tessa ;
Voorbij, Heronimus A. M. ;
Zwarts, Petra ;
Belitser, Svetlana V. ;
Egberts, Toine C. G. ;
Visser, Gerard H. A. ;
Schobben, Alfred F. A. M. .
CLINICAL PHARMACOKINETICS, 2009, 48 (10) :677-683
[32]   Importance of the cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol [J].
Suzuki, Y ;
Someya, T ;
Shimoda, K ;
Hirokane, G ;
Morita, S ;
Yokono, A ;
Inoue, Y ;
Takahashi, S .
THERAPEUTIC DRUG MONITORING, 2001, 23 (04) :363-368
[33]   Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus [J].
Boni, Joseph ;
Abbas, Richat ;
Leister, Cathie ;
Burns, Jaime ;
Jordan, Ronald ;
Hoffmann, Matthew ;
DeMaio, William ;
Hug, Bruce .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) :263-270
[34]   The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults [J].
Nichols, Alice I. ;
Fatato, Penny ;
Shenouda, Magdy ;
Paul, Jeffrey ;
Isler, Jennifer A. ;
Pedersen, Ronald D. ;
Jiang, Qin ;
Ahmed, Saeeduddin ;
Patroneva, Albena .
JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02) :219-228
[35]   Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development [J].
Zhou, Shu-Feng ;
Liu, Jun-Ping ;
Lai, Xin-Sheng .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (21) :2661-2805
[36]   New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme [J].
Wang, Bo ;
Yang, Li-Ping ;
Zhang, Xiao-Zhuang ;
Huang, Shui-Qing ;
Bartlam, Mark ;
Zhou, Shu-Feng .
DRUG METABOLISM REVIEWS, 2009, 41 (04) :573-643
[37]   Rational Molecular Design of a Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2D6 [J].
Ning, Jing ;
Tian, Zhenhao ;
Wang, Jiayue ;
Yan, Fei ;
Shi, Chao ;
Zhang, Shujing ;
Feng, Lei ;
Shu, Xiaohong ;
Cui, Jingnan ;
James, Tony D. ;
Ma, Xiaochi .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (41)
[38]   Mechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of Prasugrel [J].
Nishiya, Yumi ;
Hagihara, Katsunobu ;
Ito, Takashi ;
Tajima, Masami ;
Miura, Shin-ichi ;
Kurihara, Atsushi ;
Farid, Nagy A. ;
Ikeda, Toshihiko .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) :589-593
[39]   Importance of H-Abstraction in the Final Step of Nitrosoalkane Formation in the Mechanism-Based Inactivation of Cytochrome P450 by Amine-Containing Drugs [J].
Hirao, Hajime ;
Thellamurege, Nandun M. ;
Chuanprasit, Pratanphorn ;
Xu, Kai .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (12) :24692-24705
[40]   Regioselective hydroxylation of an antiarrhythmic drug, propafenone, mediated by rat liver cytochrome P450 2D2 differs from that catalyzed by human P450 2D6 [J].
Uehara, Shotaro ;
Murayama, Norie ;
Yamazaki, Hiroshi ;
Suemizu, Hiroshi .
XENOBIOTICA, 2019, 49 (11) :1323-1331